MARSHALL WACE, LLP
Q3 2021 13F-HR Holdings
Net value change ($000)
+3,554,065
(17.3%)
New positions
1125
Sold out positions
652
Turnover %
35.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Seagen Inc. | 138,965 | 592.2% |
| UBER | 128,346 | 966.8% |
| Biohaven Pharmaceutical Holding Co Ltd. | 112,324 | 42.3% |
| SKIN | 106,826 | NEW |
| CP | 106,799 | 321.8% |
| DVAX | 98,295 | NEW |
| ABNB | 87,231 | 59.3% |
| AMD | 83,407 | 777.8% |
| TECH | 76,733 | 219.1% |
| MRVI | 69,945 | 2265.8% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,922,417
(16.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|